These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7480011)

  • 1. Do related kappa agonists produce similar effects on cardiac ion channels?
    Pugsley MK; Hayes ES; Saint DA; Walker MJ
    Proc West Pharmacol Soc; 1995; 38():25-7. PubMed ID: 7480011
    [No Abstract]   [Full Text] [Related]  

  • 2. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.
    Pugsley MK; Saint DA; Penz MP; Walker MJ
    Br J Pharmacol; 1993 Dec; 110(4):1579-85. PubMed ID: 8306104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.
    Pugsley MK; Saint DA; Hayes ES; Kramer D; Walker MJ
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):863-74. PubMed ID: 9869491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and antiarrhythmic properties of protamine in rats.
    Pugsley MK; Kalra V; Froebel-Wilson S; Aardalen K
    Proc West Pharmacol Soc; 2001; 44():33-6. PubMed ID: 11793988
    [No Abstract]   [Full Text] [Related]  

  • 6. Action of kappa and Delta opioid agonists on premotor cardiac vagal neurons in the nucleus ambiguus.
    Wang X; Dergacheva O; Griffioen KJ; Huang ZG; Evans C; Gold A; Bouairi E; Mendelowitz D
    Neuroscience; 2004; 129(1):235-41. PubMed ID: 15489045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of myocardial slow channels by bepridil (CERM-1978).
    Vogel S; Crampton R; Sperelakis N
    J Pharmacol Exp Ther; 1979 Sep; 210(3):378-85. PubMed ID: 480188
    [No Abstract]   [Full Text] [Related]  

  • 8. EEG spectral analysis of the neuroprotective kappa opioids enadoline and PD117302.
    Tortella FC; Rose J; Robles L; Moreton JE; Hughes J; Hunter JC
    J Pharmacol Exp Ther; 1997 Jul; 282(1):286-93. PubMed ID: 9223566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U-50,488H, a kappa opioid receptor agonist, is a more potent blocker of cardiac sodium channels than lidocaine.
    Pugsley MK; Yu EJ; Goldin AL
    Proc West Pharmacol Soc; 2000; 43():47-50. PubMed ID: 11056955
    [No Abstract]   [Full Text] [Related]  

  • 10. [Frequency-dependent blockade of sodium channels in isolated rat myocardial cells by the anti-arrhythmia agent ethmozine].
    Schubert B; Hering S; Bodewei R; Wollenberger A
    Biull Eksp Biol Med; 1986 May; 101(5):581-3. PubMed ID: 2423153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specificity of the anti-arrhythmic effect of kappa1-opioid receptor agonists].
    Ugdyzhekova DS; Maslov LN; Krylatov AV; Lishmanov IuB; Tam SV
    Eksp Klin Farmakol; 2001; 64(4):17-20. PubMed ID: 11589101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
    Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
    J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal administration of kappa-opioid receptor antisense exacerbates isolation-induced hypertension.
    Wright RC; Ingenito AJ
    Neuropeptides; 2000 Dec; 34(6):360-7. PubMed ID: 11162293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time- and voltage-dependent block of sodium channels expressed in Xenopus oocytes by RSD 921, a novel class I antiarrhythmic drug.
    Pugsley MK; Goldin AL
    Proc West Pharmacol Soc; 1998; 41():75-6. PubMed ID: 9836249
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-arrhythmic effects of kappa-opioid receptor and its changes in ischemia and reperfusion.
    Jin-Cheng L; Wen Y; Zhao Y; Quan-Yu Z; Shu-Miao Z; Hai-Tao G; Hui B; Yue-Min W; Xin S; Liang C; Qin C; Shi-Qiang Y; Kaye AD; Ding-Hua Y; Jian-Ming P
    Arch Med Res; 2008 Jul; 39(5):483-8. PubMed ID: 18514092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker, (2-Isopropyl-5-methylcyclohexyl) diphenylphosphine oxide, in rat and nonhuman primate.
    Regan CP; Wallace AA; Cresswell HK; Atkins CL; Lynch JJ
    J Pharmacol Exp Ther; 2006 Feb; 316(2):727-32. PubMed ID: 16243963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cardiac muscle of two drugs related to amiodarone, L8040 and L8462.
    Vaughan Williams EM; Polster P
    Eur J Pharmacol; 1974 Feb; 25(2):241-7. PubMed ID: 4435026
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs.
    Brooks DP; Valente M; Petrone G; Depalma PD; Sbacchi M; Clarke GD
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1176-83. PubMed ID: 9067301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
    Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
    Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys.
    Butelman ER; France CP; Woods JH
    J Pharmacol Exp Ther; 1995 Oct; 275(1):374-80. PubMed ID: 7562573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.